Two major deals closed, but no recognition for U.S. trade chief Lighthizer

(Reuters) – U.S. Trade Representative Robert Lighthizer was looking forward to some holiday peace and quiet after wrapping up trade deals with the United States’ most important trading partners – China, Mexico, and Canada – last week.

Instead, the long-standing member of President Donald Trump’s inner circle who normally eschews public appearances found himself doing wall-to-wall interviews, scrambling to correct a misunderstanding with the Mexican government and taking heat from his fellow Republicans in Congress.

The conservative Wall Street Journal carried an opinion piece that said the Trump administration had bowed to “politically managed trade” in agreeing to Democratic demands to revamp the new U.S.-Mexico-Canada Agreement (USMCA), while former USTR officials and investment analysts panned the Phase 1 U.S.-China trade deal as falling far short of expectations.

Lighthizer, 72, is an anomaly in today’s hyper-partisan Washington, a powerful member of Trump’s White House who has won sometimes grudging praise from Democrats and Republicans, while keeping the ear and respect of the president throughout.

The USTR chief was “the most present person from this administration that I have seen in my three years in Congress,” said U.S. Representative Jimmy Panetta, a Democrat. “He was all over the place, and I think that helped out quite a bit.”

Richard Trumka, the president of the AFL-CIO labor union, whose support for USMCA was critical to ensuring congressional backing, called Lighthizer “an honorable man,” adding, “I’ve worked with him for 35, 40 years, and we’ve always been able to work deals out because I know when he tells me something, it’s good.”

The USMCA, which will replace the North American Free Trade Agreement, and the China trade deal were two of Trump’s top priorities, and landing them both in the same week was a public relations triumph.

But the efforts to reel in those deals took longer and proved harder than expected, and triggered further questions.



Comments

comments

more recommended stories

doctoranytime BUSQUE A UN MÉDICO